Aug 8 (Reuters) - Mesoblast Ltd on Monday said its
experimental stem-cell treatment led to significant improvements
of symptoms and disease activity in patients whose rheumatoid
arthritis had stopped being helped by widely used biotech
medicines, according to data from a mid-stage trial.
Read more
No comments:
Post a Comment